Delivery Order SPE2DB25D3108-SPE2DB25FPCBD

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,105.76 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules, with a completion date of September 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $4,829.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, with a completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of 120 count 1 gram capsules of Icosapent Ethyl, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,132.46, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 7, 2023. The contract has a final completion date of November 8, 2023 and is structured as a firm fixed-price delivery order. No set-aside designations were used for this award. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
The federal contract award SPE2DB20D3505|SPE2DB23FT6H4 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,412.31 fixed-price delivery order is for the supply of 4559771141 - Icosapent Ethyl 1 Gram Capsule 120s, with a completion date of January 31, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,229.78 for the pharmaceutical product Icosapent Ethyl 1 gram capsules. The contract was awarded by the Defense Logistics Agency (DLA) on January 20, 2023, with a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $2,581.59, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,035.37 contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty...
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPCBD
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,370.64 delivery order is for the supply of icosapent ethyl 1 gram capsules, a cardiovascular medication. This award is under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:33 AM